Nov 27 (Reuters) - Canada's health regulator has approved Novo Nordisk's (NOVOb.CO), opens new tab weight loss drug Wegovy to reduce the risk of nonfatal heart attack or myocardial infarction in some ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback